| Symbol | TLTFF |
|---|---|
| Name | THERALASE TECHNOLOGIES INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | M4B 3G4 Canada ON 41 Hollinger Road |
| Telephone | +1 416-699-5273 |
| Fax | — |
| — | |
| Website | http://www.theralase.com |
| Incorporation | CA |
| Incorporated On | 1989 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Dale Matheson Carr-Hilton Labonte LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: TSX Venture Exchange |
| CIK | 0000923883 |
| Description | Theralase Technologies Inc. ("Theralase" or "Company") (TSXV: TLT) (OTCQB: TLTFF) is a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds and their associated drug formulations to safely and effectively destroy various cancers. The Company in its Laser Division designs, manufactures and distributes patented and proprietary medical laser technology. Additional info from OTC: |